# MAINTAIN (Mucosal AblatIoN Therapy After INcretins)

> **NCT06734312** · NA · RECRUITING · sponsor: **Dr. Christopher McGowan** · enrollment: 20 (estimated)

## Conditions studied

- Obesity and Obesity-related Medical Conditions
- Obesity and Overweight
- Obesity Prevention
- Obesity Recidivism
- GLP-1
- Ablation Techniques

## Interventions

- **DEVICE:** Gastric Fundal Mucosal Ablation (GFMA)

## Key facts

- **NCT ID:** NCT06734312
- **Lead sponsor:** Dr. Christopher McGowan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06734312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06734312, "MAINTAIN (Mucosal AblatIoN Therapy After INcretins)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06734312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*